(Q43568696)

24 November 2017

Economic implications of early treatment of migraine with sumatriptan tablets (English)

1 reference

24 November 2017

1 reference

3

Lipton RB

1 reference

24 November 2017

Cady RK

1

1 reference

24 November 2017

Sheftell F

series ordinal

2

1 reference

24 November 2017

Kwong WJ

series ordinal

4

1 reference

24 November 2017

O'Quinn S

series ordinal

5

1 reference

24 November 2017

1 February 2001

1 reference

24 November 2017

Clinical Therapeutics

1 reference

24 November 2017

23

1 reference

24 November 2017

2

1 reference

24 November 2017

284-291

1 reference

Effect of early intervention with sumatriptan on migraine pain: retrospective analyses of data from three clinical trials

24 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980011-4

7 January 2021

Treatment of Mild Headache in Disabled Migraine Sufferers: Results of the Spectrum Study

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980011-4

7 January 2021

Comparing dihydroergotamine mesylate and sumatriptan in the management of acute migraine. A retrospective cost-efficacy analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980011-4

7 January 2021

Economic evaluation of oral sumatriptan compared with oral caffeine/ergotamine for migraine

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980011-4

7 January 2021

Cost-benefit analysis of sumatriptan tablets versus usual therapy for treatment of migraine

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980011-4

7 January 2021

Efficacy and safety of sumatriptan tablets (25 mg, 50 mg, and 100 mg) in the acute treatment of migraine: defining the optimum doses of oral sumatriptan

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980011-4

7 January 2021

Sumatriptan injection reduces productivity loss during a migraine attack: results of a double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980011-4

7 January 2021

10.1016/S0149-2918(01)80011-4

Identifiers

DOI

1 reference

24 November 2017

1 reference